comparative effectiveness

Research in Review

Chronic Cancer Survivors in Need of Improved Survivorship Care Plans

06/30/2017

JCP Editors

Survivors of chronic cancer are often not receiving optimal survivorship care plans and follow-up treatment, according to a study published in Cancer (published online June 27, 2017;...

...

06/30/2017

Journal of Clinical Pathways

Research in Review

Decreasing TKI Dosage Provides Better Outcomes in CML, Lowers Costs

06/29/2017

JCP Editors

Patients with chronic myeloid leukemia (CML) who receive half the standard dose of tyrosine kinase inhibitor (TKI) therapy are likely to eliminate most adverse events, drastically reduce costs, and improve...

...

06/29/2017

Journal of Clinical Pathways

Research in Review

Risk Stratification, Therapy Intensification Improves Prognosis in Adult ALL

06/29/2017

JCP Editors

Adult patients with a type of acute lymphoblastic leukemia (ALL) may benefit from the use of response-based risk stratification and therapy intensification used in pediatric disease. Early thymic precursor (ETP)-ALL...

Adult...

06/29/2017

Journal of Clinical Pathways

Research in Review

Adjuvant Ovarian Function Suppression Improves Breast Cancer Treatment Outcomes

06/29/2017

JCP Editors

In younger women with hormone receptor (HR)-positive breast cancer, ovarian function suppression (OFS) after surgery drives large improvements in breast cancer-free interval when combined with drug therapy, according...

In...

06/29/2017

Journal of Clinical Pathways

Research in Review

Best Cost-Effective Option for Breakthrough Cancer Pain Revealed

06/28/2017

JCP Editors

A cost-effectiveness analysis assessed oral fentanyl formulations available for the treatment of breakthrough cancer pain, published in PLOS One (published online June 27, 2017;...

A...

06/28/2017

Journal of Clinical Pathways

Research in Review

Targeted Therapy Improves Survival in Older Patients With B-Cell Malignancy

06/27/2017

JCP Editors

A targeting agent is more effective in improving progression-free survival (PFS) and overall survival (OS) than conventional therapy in older patients with a treatment-naïve B-cell malignancy, according to research...

A...

06/27/2017

Journal of Clinical Pathways

Research in Review

Underused Blood Test Helps Alter Treatment Strategy for Colon Cancer

06/26/2017

JCP Editors

A routinely available blood test can help improve risk stratification and guide additional therapy for stage II colon cancer. ----- Related Content Adjuvant Chemotherapy Improves Colon Cancer Outcomes Colon...

A...

06/26/2017

Journal of Clinical Pathways

Research in Review

Cost-Effective Substitute for Breast Cancer MRI Identified

06/26/2017

JCP Editors

A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...

A...

06/26/2017

Journal of Clinical Pathways

Research in Review

Triplet Combination Shows Long-Term Efficacy in Advanced Multiple Myeloma

06/26/2017

JCP Editors

Combination therapy involving a novel treatment is associated with reduced risk of death and improved progression-free survival (PFS) in patients with advanced multiple myeloma, according to research presented at the...

...

06/26/2017

Journal of Clinical Pathways

Research in Review

NSCLC Treatment Patterns, OS Data Aids Clinical Practice Benchmark Initiatives

06/26/2017

JCP Editors

Results of a recent study offer insight into the effects of shifting treatment patterns of non-small cell lung cancer (NSCLC) treatment on patient outcomes, and for furthering community oncology benchmark...

...

06/26/2017

Journal of Clinical Pathways